Effective of Early Treatment of Insomnia on the Adherence of CPAP (NCT07556432) | Clinical Trial Compass
Not Yet RecruitingNot Applicable
Effective of Early Treatment of Insomnia on the Adherence of CPAP
120 participantsStarted 2026-06-01
Plain-language summary
This study includes patients suffering from both sleep apnea and insomnia. All participants receive treatment with CPAP. Half of the participants additionally receive a digital program to treat insomnia, initiated at the same time as CPAP. The other half follows usual care and will be able to access the program after 6 months. The aim is to determine whether treating insomnia earlier improves CPAP use and overall health.
Who can participate
Age range45 Years – 65 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion criteria
✓. 45-65 years of age
✓. Diagnosis of OSAS by respiratory polygraphy or polysomnography with an apnea-hypopnea index (AHI) ≥20 when scored by PSG or ≥15 when scored by PG30 with a prescription for CPAP therapy
✓. Diagnosis of chronic insomnia according to the International Classification of Sleep Disorders (ICSD 3-TR).31
✓. Ability to communicate in French
✓. Ability to provide informed consent
✓. Accept to receive information about incidental findings
✓. Ownership of a smartphone running at least Android 9 (API version 28+) or iOS 12.2+.
Exclusion criteria
✕. Current treatment for OSAS
✕. Current or past treatment for chronic insomnia (CBT-I)